[2型糖尿病的药物治疗]

Q4 Medicine Neurological Surgery Pub Date : 2024-11-01 DOI:10.11477/mf.1436205031
Hideaki Otsuka, Tomoko Nagamine, Masato Iwabu
{"title":"[2型糖尿病的药物治疗]","authors":"Hideaki Otsuka, Tomoko Nagamine, Masato Iwabu","doi":"10.11477/mf.1436205031","DOIUrl":null,"url":null,"abstract":"<p><p>Diabetes management primarily aims to achieve a life expectancy and quality of life similar to that of people without diabetes. The key to achieving this goal is the effective prevention and management of both the microvascular and macrovascular complications associated with diabetes. Although glycated hemoglobin levels of less than 7% are recommended to minimize complications, individual targets should be set considering variables such as age, duration of diabetes, risk of hypoglycemia, organ function, support system, general health status, and social background. Treatment decisions should be individualized according to each patient's diabetes status and guided by the latest evidence on diabetes pharmacotherapy.</p>","PeriodicalId":35984,"journal":{"name":"Neurological Surgery","volume":"52 6","pages":"1144-1154"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Pharmacological Treatment for Type 2 Diabetes].\",\"authors\":\"Hideaki Otsuka, Tomoko Nagamine, Masato Iwabu\",\"doi\":\"10.11477/mf.1436205031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Diabetes management primarily aims to achieve a life expectancy and quality of life similar to that of people without diabetes. The key to achieving this goal is the effective prevention and management of both the microvascular and macrovascular complications associated with diabetes. Although glycated hemoglobin levels of less than 7% are recommended to minimize complications, individual targets should be set considering variables such as age, duration of diabetes, risk of hypoglycemia, organ function, support system, general health status, and social background. Treatment decisions should be individualized according to each patient's diabetes status and guided by the latest evidence on diabetes pharmacotherapy.</p>\",\"PeriodicalId\":35984,\"journal\":{\"name\":\"Neurological Surgery\",\"volume\":\"52 6\",\"pages\":\"1144-1154\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurological Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11477/mf.1436205031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11477/mf.1436205031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

糖尿病管理的主要目标是达到与非糖尿病患者相似的预期寿命和生活质量。实现这一目标的关键是有效预防和管理与糖尿病相关的微血管和大血管并发症。虽然建议糖化血红蛋白水平低于7%以减少并发症,但应考虑年龄、糖尿病病程、低血糖风险、器官功能、支持系统、一般健康状况和社会背景等因素来设定个体目标。治疗决定应根据每位患者的糖尿病状况,并以糖尿病药物治疗的最新证据为指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Pharmacological Treatment for Type 2 Diabetes].

Diabetes management primarily aims to achieve a life expectancy and quality of life similar to that of people without diabetes. The key to achieving this goal is the effective prevention and management of both the microvascular and macrovascular complications associated with diabetes. Although glycated hemoglobin levels of less than 7% are recommended to minimize complications, individual targets should be set considering variables such as age, duration of diabetes, risk of hypoglycemia, organ function, support system, general health status, and social background. Treatment decisions should be individualized according to each patient's diabetes status and guided by the latest evidence on diabetes pharmacotherapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurological Surgery
Neurological Surgery Medicine-Medicine (all)
自引率
0.00%
发文量
99
期刊最新文献
[Cervical Artificial Disc Replacement]. [Cervical Cord/Root Decompression:Posterior Approach/Variation of Surgical Procedure]. [Lateral Lumbar Interbody Fusion(XLIF & OLIF):Indications, X-ray Fluoroscopy-guided and 3D-CT Spinal Navigation Techniques, and Safe Surgical Practices to Prevent Complications]. [Current Consensus and Challenges of Fluorescence Imaging Technology in the Surgery of Spinal Intramedullary Tumors]. [Direct Surgery for Spinal Arteriovenous Shunt Disease: Indication and Technical Tips].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1